Table 1. Clinical Characteristics of Patients With vs Without UVFIa.
Characteristic | UVFI (n = 7) | No UVFI (n = 93) | OR (95% CI) |
---|---|---|---|
Demographics | |||
Age, median (range), y | 62.0 (39.0-77.0) | 58.0 (19.0-87.0) | 1.0 (0.9-1.1) |
Male sex | 4 (57) | 58 (62) | 0.8 (0.2-3.8) |
White race | 5 (71) | 76 (82) | 0.9 (0.1-7.9) |
BMI, median (range) | 34.7 (22.1-60.3) | 29.6 (14.4-77.0) | 1.0 (0.9-1.1) |
Comorbidities | |||
Myocardial infarction | 2 (29) | 16 (17) | 1.9 (0.3-10.8) |
Percutaneous coronary intervention, stent, or angina | 3 (43) | 12 (13) | 5.1 (1.0-25.5) |
Chronic pulmonary disease | 3 (43) | 32 (34) | 1.4 (0.3-6.8) |
Congestive heart failure | 3 (43) | 25 (27) | 2.0 (0.4-9.8) |
Hypertension requiring medical therapy | 3 (43) | 47 (51) | 0.7 (0.2-3.5) |
Peripheral vascular disease | 3 (43) | 10 (11) | 6.2 (1.2-31.9) |
Transient ischemic attack or cerebrovascular accident | 1 (14) | 7 (8) | 2.0 (0.2-19.5) |
Diabetes | 2 (29) | 34 (37) | 0.7 (0.1-3.8) |
Charlson Comorbidity Index, median (range) | 6 (3-8) | 5 (0-13) | 1.0 (0.8-1.3) |
Modified Frailty Index Score, median (range) | 0.18 (0-0.64) | 0.18 (0-0.91) | 5.5 (0.2-161.0) |
Active problems during intubation | |||
Hypotension | 7 (100) | 43 (46) | 11 (1.6-∞) |
Vasopressor requirement | 7 (100) | 33 (35) | 17 (2.4-∞) |
Acute kidney injury | 5 (71) | 44 (47) | 2.8 (0.5-15) |
Systemic corticosteroids | 4 (57) | 28 (30) | 3.1 (0.6-15) |
Delirium | 5 (71) | 63 (68) | 1.2 (0.2-6.5) |
Pneumonia | 2 (29) | 35 (38) | 0.7 (0.1-3.6) |
Acute respiratory distress syndrome | 1 (14) | 10 (11) | 1.4 (0.2-12.7) |
Nasogastric or orogastric tube | 4 (57) | 58 (62) | 0.8 (0.2-3.8) |
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); OR, odds ratio; UVFI, unilateral vocal fold immobility.
Data are presented as number (percentage) of patients unless otherwise indicated.